The need for coordinated action against falsified and substandard medicines

被引：3

作者：

Seear, Michael ^{[1
]}

机构：

[1] BCs Childrens Hosp, Div Resp Med, Vancouver, BC, Canada

来源：

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2013年 / 17卷 / 03期

关键词：

DRUGS;

D O I：

10.5588/ijtld.12.0988

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：286 / 286

页数：1

共 6 条

[1]

Attaran A, 2012, BRIT MED J, V345, pe6724

[2] Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis [J].

Bate, R. ;

Jensen, P. ;

Hess, K. ;

Mooney, L. ;

Milligan, J. .

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (03) :308-311

[3]

Chan M, 2012, 1 M MEMB STAT MECH S

[4] Counterfeit anti-infective drugs [J].

Newton, Paul N. ;

Green, Michael D. ;

Fernandez, Facundo M. ;

Day, Nicholas P. J. ;

White, Nicholas J. .

LANCET INFECTIOUS DISEASES, 2006, 6 (09) :602-613

[5] The need for better data about counterfeit drugs in developing countries: a proposed standard research methodology tested in Chennai, India [J].

Seear, M. ;

Gandhi, D. ;

Carr, R. ;

Dayal, A. ;

Raghavan, D. ;

Sharma, N. .

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (04) :488-495

[6]

WHO, 2012, COUNT MED

← 1 →